Weibing Zhou

775 total citations
21 papers, 265 citations indexed

About

Weibing Zhou is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Weibing Zhou has authored 21 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Weibing Zhou's work include Cancer-related Molecular Pathways (4 papers), Glioma Diagnosis and Treatment (3 papers) and RNA modifications and cancer (3 papers). Weibing Zhou is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Glioma Diagnosis and Treatment (3 papers) and RNA modifications and cancer (3 papers). Weibing Zhou collaborates with scholars based in China and United States. Weibing Zhou's co-authors include Juan Huang, Wuzhong Jiang, Lunquan Sun, Yuanping Hu, Zhan Wang, Li Xiong, Zhan Wang, Zhicheng Gong, Linglong Yin and Juan Chen and has published in prestigious journals such as Cancer Research, International Journal of Radiation Oncology*Biology*Physics and Corrosion Science.

In The Last Decade

Weibing Zhou

17 papers receiving 258 citations

Peers

Weibing Zhou
Yuchen Xie China
Takuya Kuramoto Japan
Tianlu Wang China
Guangrong Lu China
Zhengmao Lu China
Piao Zhao China
Richard Ottman United States
Hao‐Hao Wang China
Ning Dou China
Yuchen Xie China
Weibing Zhou
Citations per year, relative to Weibing Zhou Weibing Zhou (= 1×) peers Yuchen Xie

Countries citing papers authored by Weibing Zhou

Since Specialization
Citations

This map shows the geographic impact of Weibing Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weibing Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weibing Zhou more than expected).

Fields of papers citing papers by Weibing Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weibing Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weibing Zhou. The network helps show where Weibing Zhou may publish in the future.

Co-authorship network of co-authors of Weibing Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Weibing Zhou. A scholar is included among the top collaborators of Weibing Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weibing Zhou. Weibing Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Liu, Gui, Guihua Wang, Weibing Zhou, et al.. (2020). Comparison of Dosimetric Gains Provided by Intensity‐Modulated Radiotherapy, Volume‐Modulated Arc Therapy, and Helical Tomotherapy for High‐Grade Glioma. BioMed Research International. 2020(1). 4258989–4258989. 10 indexed citations
4.
Chen, Xiang, Wenjing Zeng, Weibing Zhou, et al.. (2020). Radiation-Enhanced Expression of CCL22 in Nasopharyngeal Carcinoma is Associated With CCR4+ CD8 T Cell Recruitment. International Journal of Radiation Oncology*Biology*Physics. 108(1). 126–139. 22 indexed citations
5.
Wang, Zhan, Min Zhang, Yujie Wang, et al.. (2019). MTMR3 is upregulated in patients with breast cancer and regulates proliferation, cell cycle progression and autophagy in breast cancer cells. Oncology Reports. 42(5). 1915–1923. 16 indexed citations
6.
7.
Hu, Xueli, Hui Li, Feiyu Chen, et al.. (2017). [p53 gene mutations of familial breast cancer and early-onset breast cancer in part population of southern China].. PubMed. 42(5). 493–500. 1 indexed citations
8.
Wang, Zhan, Juan Chen, Meizuo Zhong, et al.. (2017). Overexpression of ANLN contributed to poor prognosis of anthracycline-based chemotherapy in breast cancer patients. Cancer Chemotherapy and Pharmacology. 79(3). 535–543. 37 indexed citations
9.
Liu, Youhong, Yijun Liu, Bowen Yuan, et al.. (2017). FOXM1 promotes the progression of prostate cancer by regulating PSA gene transcription. Oncotarget. 8(10). 17027–17037. 33 indexed citations
10.
Candas, Demet, Lu Zhang, Cheikh Menaa, et al.. (2017). Abstract LB-226: Dual inhibition of CD47 and HER2 to radiosensitize breast cancer cells. Cancer Research. 77(13_Supplement). LB–226. 1 indexed citations
11.
Wang, Yujie, et al.. (2016). [Inhibition of cellular proliferation by knockdown of MARCH6 gene expression in breast cancer cells].. PubMed. 41(10). 1009–1015. 3 indexed citations
12.
Zhou, Weibing, Zhan Wang, Wuzhong Jiang, et al.. (2014). Knockdown of ANLN by lentivirus inhibits cell growth and migration in human breast cancer. Molecular and Cellular Biochemistry. 398(1-2). 11–19. 76 indexed citations
13.
Zhou, Yingying, Weibing Zhou, Qiong Liu, et al.. (2013). XRCC1 R399Q polymorphism and risk of normal tissue injury after radiotherapy in breast cancer patients. Tumor Biology. 35(1). 21–25. 5 indexed citations
14.
Zhou, Weibing, et al.. (2012). p12CDK2-AP1 inhibits breast cancer cell proliferation and in vivo tumor growth. Journal of Cancer Research and Clinical Oncology. 138(12). 2085–2093. 16 indexed citations
15.
Zhou, Weibing, et al.. (2011). [Efficacy and safety of 3-dimensional conformal radiotherapy combined with temozolomide for glioma].. PubMed. 36(11). 1106–10. 2 indexed citations
16.
Zhou, Weibing, et al.. (2009). Clinical observation of Xiaoaiping combined with concurrent chemoradiotherapy in advanced nasopharyngeal cancer.. Chinese Clinical Oncology. 14(11). 1029–1031. 2 indexed citations
17.
Zhang, Yingying, et al.. (2009). [Dosimetric verification and clinical efficacy of intensity modulated radiotherapy in nasopharyngeal carcinoma].. PubMed. 34(9). 879–85. 1 indexed citations
18.
Zhou, Weibing, et al.. (2000). Mechanism of the significant improvement in corrosion protection by lowering water sorption of the coating. Corrosion Science. 42(12). 2037–2041. 33 indexed citations
19.
Cai, Wen–Bin, et al.. (1997). Comparison of the reduction behaviour of anodic PbO2 films on Pb-As and Pb-Bi alloys in sulfuric acid. Journal of Applied Electrochemistry. 27(10). 1212–1216. 1 indexed citations
20.
Xia, Shijing & Weibing Zhou. (1994). Anodic film on lead-arsenic alloy in sulphuric acid medium. Journal of Applied Electrochemistry. 24(9). 894–899. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuchen Xie Breakdown of academic impact, for papers by Takuya Kuramoto Breakdown of academic impact, for papers by Tianlu Wang Breakdown of academic impact, for papers by Guangrong Lu Breakdown of academic impact, for papers by Zhengmao Lu Breakdown of academic impact, for papers by Piao Zhao Breakdown of academic impact, for papers by Richard Ottman Breakdown of academic impact, for papers by Hao‐Hao Wang Breakdown of academic impact, for papers by Ning Dou
Rankless by CCL
2026